Early Clinical Response after 2 Weeks of Sorafenib Therapy Predicts Outcomes and Anti-Tumor Response in Patients with Advanced Hepatocellular Carcinoma

Early Clinical Response after 2 Weeks of Sorafenib Therapy Predicts Outcomes and Anti-Tumor Response in Patients with Advanced Hepatocellular Carcinoma

Bibliographic Details
Main Authors: Kuzuya, Teiji, Ishigami, Masatoshi, Ishizu, Yoji, Honda, Takashi, Hayashi, Kazuhiko, Katano, Yoshiaki, Hirooka, Yoshiki, Ishikawa, Tetsuya, Nakano, Isao, Goto, Hidemi
Format: Online
Language:English
Published: Public Library of Science 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4589320/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4589320/

Similar Items